MPX International (FRA:2J6) EBIT : €-13.62 Mil (TTM As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is MPX International EBIT?

MPX International's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2022 was €-3.34 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2022 was €-13.62 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. MPX International's annualized ROC % for the quarter that ended in Mar. 2022 was -36.20%. MPX International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2022 was -99.36%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. MPX International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2022 was -82.03%.

MPX International EBIT Historical Data

The historical data trend for MPX International's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MPX International EBIT Chart

MPX International Annual Data

Trend

Sep18

Sep19

Sep20

Sep21

EBIT

-1.38

-6.05

-26.21

-14.81

MPX International Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
EBIT	Get a 7-Day Free Trial												-5.28	-0.78	-7.60	-1.90	-3.34

Competitive Comparison of MPX International's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, MPX International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MPX International's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPX International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MPX International's EV-to-EBIT falls into.

MPX International EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-13.62 Mil.

MPX International (FRA:2J6) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

MPX International's annualized ROC % for the quarter that ended in Mar. 2022 is calculated as:

	ROC % (Q: Mar. 2022 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2021 )	+	Invested Capital (Q: Mar. 2022 ))	/ count )
=	-11.584 * ( 1 - -1.95% )	/	( (31.58	+	33.671)	/ 2 )
=	-11.809888	/	32.6255
=	-36.20 %

where

	Invested Capital		(Q: Dec. 2021 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	33.763	-	5.575	-	( 2.498	-	max(0, 10.535	-	7.143	+	2.498	))
=	31.58

	Invested Capital		(Q: Mar. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	33.805	-	7.024	-	( 0.657	-	max(0, 12.974	-	6.084	+	0.657	))
=	33.671

Note: The Operating Income data used here is four times the quarterly (Mar. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

MPX International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2022 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2022 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2021		Q: Mar. 2022
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-13.368	/	( ( (12.747 + max(-1.624, 0))	+	(14.162 + max(-2.395, 0)) )	/	2 )
=	-13.368	/	( ( 12.747	+	14.162 )	/	2 )
=	-13.368	/	13.4545
=	-99.36 %

where Working Capital is:

	Working Capital		(Q: Dec. 2021 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.475	+	2.644	+	0.831)	-	(5.575	+	0	+	-0.0010000000000012)
=	-1.624

	Working Capital		(Q: Mar. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.494	+	2.978	+	1.158)	-	(7.024	+	0	+	0.0010000000000012)
=	-2.395

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

MPX International's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2022 )
	=	-13.621	/	16.604
	=	-82.03 %

MPX International EBIT Related Terms

Thank you for viewing the detailed overview of MPX International's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

MPX International (FRA:2J6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MPX International Corp (FRA:2J6) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4

Website

https://www.mpxinternationalcorp.com

MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.

MPX International (FRA:2J6) Headlines

No Headlines